HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ZBH
Zimmer Biomet Holdings Inc
Healthcare Medical Devices · Indiana, USA · Reports in usd
Market Cap: $18.35B
Market Cap
$18.35B
Enterprise Val
$25.28B
P/E Ratio
26.03
P/B Ratio
1.45
Trailing PEG (1Y)
-0.64
As Of
Apr 26, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$12.71B
Gross Margin64.68%
Profit Margin64.68%
Return on Equity5.60%
Return on Assets3.08%
Current Ratio1.98
Debt/Equity0.59
LT Debt/Equity0.55
Revenue Per Share11.32

Income Statement

Dec 31, 2025
Revenue$2.24B
Cost of Revenue$792.4M
Gross Profit$1.45B
R&D$118.7M
SG&A$872.3M
Operating Expenses$1.30B
Operating Income$154.5M
Interest Expense$71.9M
Tax Expense-$39.9M
Net Income$139.3M
EPS (Basic)$0.71
EPS (Diluted)$0.71
EBIT$171.3M
EBITDA$455.3M
Consolidated Income$137.9M
Non-Controlling Interests-$1.5M

Balance Sheet

Dec 31, 2025
Cash & Equivalents$591.9M
Accounts Receivable$1.70B
Inventory$2.29B
Current Assets$5.12B
LT Investments$0.00
Property, Plant & Equipment$2.21B
Intangibles$14.66B
Non-Current Assets$17.97B
Total Assets$23.09B
Accounts Payable$303.0M
Current Debt$587.1M
Current Liabilities$2.58B
LT Debt$6.93B
Non-Current Liabilities$7.80B
Total Liabilities$10.39B
Total Debt$7.52B
Retained Earnings$11.61B
Shareholder Equity$12.70B
Shares Outstanding198,181,555

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$517.4M
Investing Cash Flow-$322.0M
Financing Cash Flow-$897.0M
CapEx-$149.1M
Free Cash Flow$368.3M
Depreciation & Amort.$284.0M
Stock-Based Comp$24.1M
Acquisitions / Disposals-$166.9M
Investment Activity$4.9M
Debt Issued/Repaid-$600.0M
Equity Issued/Repaid-$248.3M
Dividends Paid-$47.5M
Net Change in Cash-$700.8M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h